HIV 1 News and Research

RSS
Study reports new monoclonal antibodies with broad neutralizing capabilities against betacoronaviruses (including SARS-CoV-2)

Study reports new monoclonal antibodies with broad neutralizing capabilities against betacoronaviruses (including SARS-CoV-2)

SARS-CoV-2 spike mutations during transmission among humans and to animals

SARS-CoV-2 spike mutations during transmission among humans and to animals

Host cell transmembrane protein MARCH8 targets lysine residues to inhibit SARS-CoV-2 and other viruses

Host cell transmembrane protein MARCH8 targets lysine residues to inhibit SARS-CoV-2 and other viruses

Celastrol shows potential anti-SARS-CoV-2 activity

Celastrol shows potential anti-SARS-CoV-2 activity

SARS-CoV-2-associated ssRNAs trigger inflammation and immunity via toll-like receptors

SARS-CoV-2-associated ssRNAs trigger inflammation and immunity via toll-like receptors

Novel PF74 molecule effectively targets HIV capsid protein

Novel PF74 molecule effectively targets HIV capsid protein

New approach to CAR T gene therapy yields efficient and longer-lasting response against HIV

New approach to CAR T gene therapy yields efficient and longer-lasting response against HIV

Arginine methylation important in SARS-CoV-2 viral replication

Arginine methylation important in SARS-CoV-2 viral replication

Developing a COVID-19 vaccine using inactivated E. coli

Developing a COVID-19 vaccine using inactivated E. coli

Researchers explore nanotechnology’s potential to deliver synergistic therapeutics for COVID-19

Researchers explore nanotechnology’s potential to deliver synergistic therapeutics for COVID-19

New Phase 1 study evaluates prime/boost HIV-1 vaccine formulated with combinations of adjuvants

New Phase 1 study evaluates prime/boost HIV-1 vaccine formulated with combinations of adjuvants

Scientists increase potency of HIV-1 antibody, identify new ways to develop vaccines

Scientists increase potency of HIV-1 antibody, identify new ways to develop vaccines

Neutralizing antibodies may be evolving to keep up with SARS-CoV-2 mutations

Neutralizing antibodies may be evolving to keep up with SARS-CoV-2 mutations

Research shows effective strategy to target the SARS-CoV-2 spike protein

Research shows effective strategy to target the SARS-CoV-2 spike protein

Cannabinoid receptor agonist shows potential protective effect on SARS-CoV-2-infected human heart cells

Cannabinoid receptor agonist shows potential protective effect on SARS-CoV-2-infected human heart cells

Researchers use high-resolution imaging to observe HIV infection process in the cell nucleus

Researchers use high-resolution imaging to observe HIV infection process in the cell nucleus

Are antibody cocktails the key to COVID-19 treatment?

Are antibody cocktails the key to COVID-19 treatment?

HIV: New therapeutic approach to restore the effectiveness of immune cells

HIV: New therapeutic approach to restore the effectiveness of immune cells

SHREK proteins mediate broad spectrum antiviral host immunity, including against SARS-CoV-2

SHREK proteins mediate broad spectrum antiviral host immunity, including against SARS-CoV-2

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

Phase 1 clinical trial of novel HIV vaccine approach shows promising results